Sign inGet started

DEERFIELD MANAGEMENT CO /NY

Insider CIK 1009258 · STRM 10% owner · AVDL 10% owner · ATRS 10% owner · CBIO 10% owner · LUMO 10% owner · XNPT 10% owner · TLON.OB 10% owner · AUXL 10% owner · ALIM 10% owner · EHTH 10% owner · AERI 10% owner · LIFE 10% owner · XERS 10% owner · VNDA 10% owner · PRTO Director, 10% owner · ZFGN Director, 10% owner · IVTY 10% owner · DRNA 10% owner · TRIV 10% owner · CNST 10% owner · ASPX 10% owner · NEOS 10% owner · SDGR 10% owner · NVTA 10% owner · AAVL 10% owner · CTMX 10% owner · AFIB Director, 10% owner · ANNX 10% owner · GRAY 10% owner · SYRS 10% owner · ACRS 10% owner · MNK 10% owner · GUTS 10% owner · LOXO 10% owner · REPH 10% owner · RGNX 10% owner · STDY 10% owner · NVLS Director, 10% owner · RVMD 10% owner · BOLD 10% owner · SWAV 10% owner · RYTM 10% owner · EDIT 10% owner · AVXS 10% owner · ARVN 10% owner · PBLS 10% owner · FIXX Director, 10% owner · ONCR Director, 10% owner · SPRY 10% owner · BDTX 10% owner · FREQ 10% owner · EWTX 10% owner · DFBH Director, 10% owner · KNSA 10% owner · GBIO 10% owner · PHGE Director, 10% owner · CABA 10% owner · MIRM 10% owner · HOWL 10% owner · NKTX 10% owner · DFPH Director, 10% owner · DFHT Director, 10% owner · TERN 10% owner · PEPG 10% owner · XLO 10% owner · OMIC 10% owner · NUVL Director, 10% owner · DALS Director, 10% owner · BCAX 10% owner · CASM 10% owner · AXGN 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NUVL Nuvalent, Inc. D To issuer deriv2026-07-152026-07-1720,000— $00SEC↗
NUVL Nuvalent, Inc. D To issuer deriv2026-07-152026-07-1720,000— $00SEC↗
NUVL Nuvalent, Inc. D To issuer deriv2026-07-152026-07-1743,000— $00SEC↗
NUVL Nuvalent, Inc. D To issuer deriv2026-07-152026-07-1743,000— $00SEC↗
NUVL Nuvalent, Inc. D To issuer deriv2026-07-152026-07-172,717,627$124.00 $336.99M0SEC↗
NUVL Nuvalent, Inc. D To issuer deriv2026-07-152026-07-172,717,627$124.00 $336.99M0SEC↗
NUVL Nuvalent, Inc. D To issuer deriv2026-07-152026-07-1715,000— $00SEC↗
NUVL Nuvalent, Inc. D To issuer deriv2026-07-152026-07-173,789— $00SEC↗
NUVL Nuvalent, Inc. D To issuer deriv2026-07-152026-07-173,789— $00SEC↗
NUVL Nuvalent, Inc. D To issuer deriv2026-07-152026-07-174,147— $00SEC↗
NUVL Nuvalent, Inc. D To issuer deriv2026-07-152026-07-174,147— $00SEC↗
NUVL Nuvalent, Inc. D To issuer deriv2026-07-152026-07-1715,000— $00SEC↗
NUVL Nuvalent, Inc. D To issuer2026-07-152026-07-178,299,225$124.00 $1.03B0SEC↗
NUVL Nuvalent, Inc. D To issuer2026-07-152026-07-178,299,225$124.00 $1.03B0SEC↗
NUVL Nuvalent, Inc. D To issuer2026-07-152026-07-17650,000$124.00 $80.60M0SEC↗
NUVL Nuvalent, Inc. U Tender2026-07-152026-07-175,146$124.00 $638.1K0SEC↗
NUVL Nuvalent, Inc. D To issuer2026-07-152026-07-173,444$124.00 $427.1K0SEC↗
NUVL Nuvalent, Inc. U Tender2026-07-152026-07-175,146$124.00 $638.1K0SEC↗
NUVL Nuvalent, Inc. A Award2026-06-162026-06-183,444— $03,444SEC↗
PBLS Parabilis Medicines, Inc. C Conversion deriv2026-06-112026-06-11246,732— $00SEC↗
PBLS Parabilis Medicines, Inc. C Conversion deriv2026-06-112026-06-11246,732— $00SEC↗
PBLS Parabilis Medicines, Inc. C Conversion deriv2026-06-112026-06-11464,550— $00SEC↗
PBLS Parabilis Medicines, Inc. C Conversion deriv2026-06-112026-06-11464,550— $00SEC↗
PBLS Parabilis Medicines, Inc. C Conversion deriv2026-06-112026-06-11143,650— $00SEC↗
PBLS Parabilis Medicines, Inc. C Conversion deriv2026-06-112026-06-11166,070— $00SEC↗
PBLS Parabilis Medicines, Inc. C Conversion deriv2026-06-112026-06-11166,070— $00SEC↗
PBLS Parabilis Medicines, Inc. C Conversion deriv2026-06-112026-06-11143,650— $00SEC↗
PBLS Parabilis Medicines, Inc. C Conversion2026-06-112026-06-11149,238— $0272,228SEC↗
PBLS Parabilis Medicines, Inc. C Conversion2026-06-112026-06-11122,990— $0122,990SEC↗
PBLS Parabilis Medicines, Inc. C Conversion2026-06-112026-06-11122,990— $0122,990SEC↗
PBLS Parabilis Medicines, Inc. C Conversion2026-06-112026-06-11149,238— $0272,228SEC↗
PBLS Parabilis Medicines, Inc. C Conversion2026-06-112026-06-11260,992— $0533,220SEC↗
PBLS Parabilis Medicines, Inc. C Conversion2026-06-112026-06-11260,992— $0533,220SEC↗
PBLS Parabilis Medicines, Inc. C Conversion2026-06-112026-06-11407,132— $0940,352SEC↗
PBLS Parabilis Medicines, Inc. C Conversion2026-06-112026-06-11407,132— $0940,352SEC↗
LRMR Larimar Therapeutics, Inc. A Award deriv2026-05-192026-05-2055,150— $055,150SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2026-02-272026-03-021,084,012$5.00 $5.42M10,622,957SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2026-02-272026-03-02831,978$5.00 $4.16M8,153,107SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2026-02-272026-03-022,000,000$5.00 $10.00M6,207,982SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2026-02-272026-03-021,084,010$5.00 $5.42M10,622,928SEC↗
NUVL Nuvalent, Inc. S Sale2025-11-242025-11-24371,287$95.45 $35.44M8,299,225SEC↗
NUVL Nuvalent, Inc. S Sale2025-11-242025-11-24371,287$95.45 $35.44M8,299,225SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2025-07-312025-08-042,599,932$3.20 $8.32M7,321,129SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2025-07-312025-08-043,387,539$3.20 $10.84M9,538,945SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2025-07-312025-08-043,387,529$3.20 $10.84M9,538,918SEC↗
SPRY ARS Pharmaceuticals, Inc. S Sale2025-06-272025-07-01370,075$18.46 $6.83M4,887,254SEC↗
SPRY ARS Pharmaceuticals, Inc. S Sale2025-06-272025-07-01370,074$18.46 $6.83M4,887,254SEC↗
NUVL Nuvalent, Inc. A Award deriv2025-06-182025-06-204,147— $04,147SEC↗
NUVL Nuvalent, Inc. A Award deriv2025-06-182025-06-204,147— $04,147SEC↗
NUVL Nuvalent, Inc. A Award2025-06-182025-06-202,647— $02,647SEC↗
NUVL Nuvalent, Inc. A Award2025-06-182025-06-202,647— $02,647SEC↗
LRMR Larimar Therapeutics, Inc. A Award deriv2025-05-132025-05-1519,000— $019,000SEC↗
PHGE BiomX Inc. A Award deriv2025-04-212025-04-231,611,864— $01,611,864SEC↗
PHGE BiomX Inc. A Award deriv2025-04-212025-04-231,611,864— $01,611,864SEC↗
PHGE BiomX Inc. A Award deriv2025-04-142025-04-1817,600— $017,600SEC↗
PHGE BiomX Inc. A Award deriv2025-02-272025-03-031,258,614— $01,258,614SEC↗
PHGE BiomX Inc. A Award deriv2025-02-272025-03-031,258,614— $01,258,614SEC↗
PHGE BiomX Inc. M Exercise deriv2025-02-272025-03-031,611,863— $0405,637SEC↗
PHGE BiomX Inc. M Exercise deriv2025-02-272025-03-031,611,863— $0405,637SEC↗
PHGE BiomX Inc. M Exercise2025-02-272025-03-03353,249$0.93 $328.5K1,247,054SEC↗
PHGE BiomX Inc. M Exercise2025-02-272025-03-03353,249$0.93 $328.5K1,247,054SEC↗
AFIB Acutus Medical, Inc. D To issuer deriv2025-01-272025-01-28193,002— $00SEC↗
AFIB Acutus Medical, Inc. D To issuer deriv2025-01-272025-01-2831,116— $00SEC↗
AFIB Acutus Medical, Inc. D To issuer deriv2025-01-272025-01-281,889,509— $00SEC↗
AFIB Acutus Medical, Inc. D To issuer deriv2025-01-272025-01-28209,996— $00SEC↗
AFIB Acutus Medical, Inc. D To issuer deriv2025-01-272025-01-281,889,509— $00SEC↗
SPRY ARS Pharmaceuticals, Inc. S Sale2024-11-122024-11-139,554$17.77 $169.8K5,257,329SEC↗
SPRY ARS Pharmaceuticals, Inc. S Sale2024-11-122024-11-137,854$17.16 $134.8K5,266,881SEC↗
SPRY ARS Pharmaceuticals, Inc. S Sale2024-11-122024-11-137,853$17.16 $134.8K5,266,883SEC↗
SPRY ARS Pharmaceuticals, Inc. S Sale2024-11-122024-11-139,553$17.77 $169.8K5,257,328SEC↗
SPRY ARS Pharmaceuticals, Inc. S Sale2024-11-112024-11-13223,632$18.15 $4.06M5,274,735SEC↗
SPRY ARS Pharmaceuticals, Inc. S Sale2024-11-112024-11-13223,632$18.15 $4.06M5,274,736SEC↗
SPRY ARS Pharmaceuticals, Inc. S Sale2024-11-112024-11-1340,596$17.45 $708.4K5,498,367SEC↗
SPRY ARS Pharmaceuticals, Inc. S Sale2024-11-112024-11-1340,596$17.45 $708.4K5,498,368SEC↗
NUVL Nuvalent, Inc. S Sale2024-10-222024-10-241,000,000$97.75 $97.75M8,670,512SEC↗
NUVL Nuvalent, Inc. S Sale2024-10-222024-10-241,000,000$97.75 $97.75M8,670,512SEC↗
BCAX Bicara Therapeutics Inc. C Conversion deriv2024-09-172024-09-177,973,325— $00SEC↗
BCAX Bicara Therapeutics Inc. C Conversion deriv2024-09-172024-09-177,973,325— $00SEC↗
BCAX Bicara Therapeutics Inc. P Buy2024-09-172024-09-1735,000$18.00 $630.0K897,587SEC↗
BCAX Bicara Therapeutics Inc. P Buy2024-09-172024-09-1735,000$18.00 $630.0K897,587SEC↗
BCAX Bicara Therapeutics Inc. C Conversion2024-09-172024-09-17862,587— $0862,587SEC↗
BCAX Bicara Therapeutics Inc. C Conversion2024-09-172024-09-17862,587— $0862,587SEC↗
PHGE BiomX Inc. M Exercise deriv2024-07-152024-07-175,883— $047,957SEC↗
PHGE BiomX Inc. M Exercise deriv2024-07-152024-07-175,883— $047,957SEC↗
PHGE BiomX Inc. M Exercise2024-07-152024-07-175,883,000— $08,938,049SEC↗
PHGE BiomX Inc. M Exercise2024-07-152024-07-175,883,000— $08,938,049SEC↗
PHGE BiomX Inc. A Award deriv2024-07-112024-07-15264,000— $0264,000SEC↗
PHGE BiomX Inc. A Award deriv2024-07-092024-07-1120,175,000— $020,175,000SEC↗
PHGE BiomX Inc. A Award deriv2024-07-092024-07-1120,175,000— $020,175,000SEC↗
PHGE BiomX Inc. A Award deriv2024-07-092024-07-11722,175— $0722,175SEC↗
PHGE BiomX Inc. A Award deriv2024-07-092024-07-11722,175— $0722,175SEC↗
NUVL Nuvalent, Inc. A Award deriv2024-06-122024-06-143,789— $03,789SEC↗
NUVL Nuvalent, Inc. A Award deriv2024-06-122024-06-143,789— $03,789SEC↗
NUVL Nuvalent, Inc. A Award2024-06-122024-06-142,499— $02,499SEC↗
NUVL Nuvalent, Inc. A Award2024-06-122024-06-142,499— $02,499SEC↗
LRMR Larimar Therapeutics, Inc. A Award deriv2024-05-292024-06-0319,000— $019,000SEC↗
PHGE BiomX Inc. A Award deriv2024-03-152024-03-1913,490— $013,490SEC↗
PHGE BiomX Inc. A Award deriv2024-03-152024-03-1940,350— $053,840SEC↗
PHGE BiomX Inc. A Award deriv2024-03-152024-03-1940,350— $053,840SEC↗
PHGE BiomX Inc. A Award deriv2024-03-152024-03-1913,490— $013,490SEC↗
PHGE BiomX Inc. A Award2024-03-152024-03-193,055,049— $03,055,049SEC↗
PHGE BiomX Inc. A Award2024-03-152024-03-193,055,049— $03,055,049SEC↗
AHCO AdaptHealth Corp. S Sale2024-03-122024-03-12114,906$10.70 $1.23M11,528,863SEC↗
AHCO AdaptHealth Corp. S Sale2024-03-112024-03-1294,567$10.92 $1.03M11,731,809SEC↗
AHCO AdaptHealth Corp. S Sale2024-03-112024-03-1288,040$11.13 $979.9K11,643,769SEC↗
AHCO AdaptHealth Corp. S Sale2024-03-082024-03-124,495$11.03 $49.6K11,826,376SEC↗
AHCO AdaptHealth Corp. S Sale2024-03-082024-03-1247,992$10.92 $524.1K11,830,871SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2024-02-162024-02-161,430,205$8.74 $12.50M4,207,982SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2024-02-162024-02-161,430,206$8.74 $12.50M6,151,389SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2024-02-162024-02-161,430,206$8.74 $12.50M6,151,406SEC↗
GUTS Fractyl Health, Inc. C Conversion deriv2024-02-062024-02-081,625,699— $00SEC↗
GUTS Fractyl Health, Inc. C Conversion deriv2024-02-062024-02-08164,612— $00SEC↗
GUTS Fractyl Health, Inc. C Conversion2024-02-062024-02-0876,706— $0834,254SEC↗
GUTS Fractyl Health, Inc. C Conversion2024-02-062024-02-08757,548— $0757,548SEC↗
CMAX CareMax, Inc. M Exercise deriv2023-11-172023-11-2112,123— $00SEC↗
CMAX CareMax, Inc. M Exercise2023-11-172023-11-2112,123— $012,123SEC↗
DALS DA32 Life Science Tech Acq J Other2023-07-282023-08-011,600,000— $00SEC↗
NUVL Nuvalent, Inc. A Award deriv2023-06-152023-06-1615,000— $015,000SEC↗
NUVL Nuvalent, Inc. A Award deriv2023-06-152023-06-1615,000— $015,000SEC↗
AFIB Acutus Medical, Inc. A Award deriv2023-06-152023-06-2019,600— $019,600SEC↗
AFIB Acutus Medical, Inc. A Award2023-06-152023-06-208,400— $020,822SEC↗
CMAX CareMax, Inc. A Award deriv2023-06-082023-06-1233,750— $033,750SEC↗
LRMR Larimar Therapeutics, Inc. A Award deriv2023-05-092023-05-118,300— $08,300SEC↗
ONCR Oncorus, Inc. S Sale2022-12-302022-12-3015,220$0.27 $4.1K284,697SEC↗
ONCR Oncorus, Inc. S Sale2022-12-302022-12-3061,826$0.27 $16.7K1,156,309SEC↗
ONCR Oncorus, Inc. S Sale2022-12-302022-12-3061,826$0.27 $16.7K1,156,308SEC↗
ONCR Oncorus, Inc. S Sale2022-12-292022-12-3063,107$0.26 $16.4K1,218,135SEC↗
ONCR Oncorus, Inc. S Sale2022-12-292022-12-3063,108$0.26 $16.4K1,218,134SEC↗
ONCR Oncorus, Inc. S Sale2022-12-292022-12-3015,538$0.26 $4.0K299,917SEC↗
ONCR Oncorus, Inc. S Sale2022-12-282022-12-3024,757$0.25 $6.2K1,281,242SEC↗
ONCR Oncorus, Inc. S Sale2022-12-282022-12-306,096$0.25 $1.5K315,455SEC↗
ONCR Oncorus, Inc. S Sale2022-12-282022-12-3024,757$0.25 $6.2K1,281,242SEC↗
ONCR Oncorus, Inc. S Sale2022-12-272022-12-277,136$0.27 $1.9K321,551SEC↗
ONCR Oncorus, Inc. S Sale2022-12-272022-12-2728,977$0.27 $7.8K1,305,999SEC↗
ONCR Oncorus, Inc. S Sale2022-12-272022-12-2728,977$0.27 $7.8K1,305,999SEC↗
ONCR Oncorus, Inc. S Sale2022-12-222022-12-273,693$0.28 $1.0K1,334,976SEC↗
ONCR Oncorus, Inc. S Sale2022-12-222022-12-273,692$0.28 $1.0K1,334,976SEC↗
ONCR Oncorus, Inc. S Sale2022-12-222022-12-27909$0.28 $255328,687SEC↗
ONCR Oncorus, Inc. S Sale2022-12-212022-12-216,144$0.30 $1.8K1,338,668SEC↗
ONCR Oncorus, Inc. S Sale2022-12-212022-12-216,143$0.30 $1.8K1,338,669SEC↗
ONCR Oncorus, Inc. S Sale2022-12-212022-12-211,513$0.30 $454329,596SEC↗
ONCR Oncorus, Inc. S Sale2022-12-202022-12-211,616$0.31 $501331,109SEC↗
ONCR Oncorus, Inc. S Sale2022-12-202022-12-216,562$0.31 $2.0K1,344,812SEC↗
ONCR Oncorus, Inc. S Sale2022-12-202022-12-216,562$0.31 $2.0K1,344,812SEC↗
ONCR Oncorus, Inc. S Sale2022-12-192022-12-2144,394$0.29 $12.9K1,351,374SEC↗
ONCR Oncorus, Inc. S Sale2022-12-192022-12-2144,394$0.29 $12.9K1,351,374SEC↗
ONCR Oncorus, Inc. S Sale2022-12-192022-12-2110,930$0.29 $3.2K332,725SEC↗
ONCR Oncorus, Inc. S Sale2022-12-152022-12-151,375$0.39 $5361,395,768SEC↗
ONCR Oncorus, Inc. S Sale2022-12-152022-12-15339$0.39 $132343,655SEC↗
ONCR Oncorus, Inc. S Sale2022-12-152022-12-151,375$0.39 $5361,395,768SEC↗
ONCR Oncorus, Inc. S Sale2022-12-142022-12-15943$0.38 $358343,994SEC↗
ONCR Oncorus, Inc. S Sale2022-12-142022-12-153,829$0.38 $1.5K1,397,143SEC↗
ONCR Oncorus, Inc. S Sale2022-12-142022-12-153,828$0.38 $1.5K1,397,143SEC↗
ONCR Oncorus, Inc. S Sale2022-12-132022-12-15934$0.41 $3831,400,971SEC↗
ONCR Oncorus, Inc. S Sale2022-12-132022-12-15933$0.41 $3831,400,972SEC↗
ONCR Oncorus, Inc. S Sale2022-12-132022-12-15230$0.41 $94344,937SEC↗
CMAX CareMax, Inc. A Award deriv2022-11-172022-11-2112,123— $012,123SEC↗
NUVL Nuvalent, Inc. P Buy2022-11-032022-11-07650,000$33.50 $21.77M650,000SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2022-09-162022-09-202,777,777$3.15 $8.75M2,777,777SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2022-09-162022-09-202,777,777$3.15 $8.75M4,721,197SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2022-09-162022-09-202,777,777$3.15 $8.75M4,721,183SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2022-09-162022-09-202,777,777$3.15 $8.75M4,721,200SEC↗
AFIB Acutus Medical, Inc. A Award deriv2022-06-302022-07-051,889,509— $01,889,509SEC↗
AFIB Acutus Medical, Inc. A Award deriv2022-06-302022-07-051,889,509— $01,889,509SEC↗
AFIB Acutus Medical, Inc. A Award deriv2022-06-162023-06-2019,600— $019,600SEC↗
AFIB Acutus Medical, Inc. A Award2022-06-162023-06-208,400— $012,422SEC↗
NUVL Nuvalent, Inc. A Award deriv2022-06-162022-06-2120,000— $020,000SEC↗
NUVL Nuvalent, Inc. A Award deriv2022-06-162022-06-2120,000— $020,000SEC↗
MIRM Mirum Pharmaceuticals, Inc S Sale2022-06-062022-06-08171$25.08 $4.3K1,711,153SEC↗
MIRM Mirum Pharmaceuticals, Inc S Sale2022-06-062022-06-086,909$24.47 $169.1K1,704,244SEC↗
MIRM Mirum Pharmaceuticals, Inc S Sale2022-06-062022-06-08155$25.08 $3.9K1,546,433SEC↗
MIRM Mirum Pharmaceuticals, Inc S Sale2022-06-062022-06-086,243$24.47 $152.8K1,540,190SEC↗
MIRM Mirum Pharmaceuticals, Inc S Sale2022-06-062022-06-0811,868$25.29 $300.1K1,546,588SEC↗
MIRM Mirum Pharmaceuticals, Inc S Sale2022-06-062022-06-0813,132$25.29 $332.1K1,711,324SEC↗
PEPG PepGen Inc. C Conversion deriv2022-05-102022-05-10273,313— $00SEC↗
PEPG PepGen Inc. C Conversion deriv2022-05-102022-05-10273,313— $00SEC↗
LRMR Larimar Therapeutics, Inc. A Award deriv2022-05-102022-05-118,300— $08,300SEC↗
PEPG PepGen Inc. P Buy2022-05-102022-05-10208,333$12.00 $2.50M476,813SEC↗
PEPG PepGen Inc. P Buy2022-05-102022-05-10208,333$12.00 $2.50M476,813SEC↗
PEPG PepGen Inc. C Conversion2022-05-102022-05-10268,480— $0268,480SEC↗
PEPG PepGen Inc. C Conversion2022-05-102022-05-10268,480— $0268,480SEC↗
DFPH Oncology Institute, Inc. C Conversion deriv2021-11-122021-11-1685,113— $00SEC↗
DFPH Oncology Institute, Inc. J Other deriv2021-11-122021-11-16625,000— $0625,000SEC↗
DFPH Oncology Institute, Inc. P Buy deriv2021-11-122021-11-1650,000$1000.00 $50.00M58,945SEC↗
DFPH Oncology Institute, Inc. P Buy deriv2021-11-122021-11-1650,000$1000.00 $50.00M58,945SEC↗
DFPH Oncology Institute, Inc. J Other deriv2021-11-122021-11-16707,960— $040SEC↗
DFPH Oncology Institute, Inc. J Other deriv2021-11-122021-11-1614,887— $085,113SEC↗
DFPH Oncology Institute, Inc. C Conversion deriv2021-11-122021-11-1640— $00SEC↗
DFPH Oncology Institute, Inc. J Other deriv2021-11-122021-11-163,177,543— $03,177,543SEC↗
DFPH Oncology Institute, Inc. J Other deriv2021-11-122021-11-16625,000— $0625,000SEC↗
DFPH Oncology Institute, Inc. C Conversion2021-11-122021-11-1685,113— $085,113SEC↗
DFPH Oncology Institute, Inc. C Conversion2021-11-122021-11-1640— $040SEC↗
XLO Xilio Therapeutics, Inc. C Conversion deriv2021-10-262021-10-287,186,489— $00SEC↗
XLO Xilio Therapeutics, Inc. C Conversion deriv2021-10-262021-10-287,186,489— $00SEC↗
XLO Xilio Therapeutics, Inc. C Conversion2021-10-262021-10-28756,472— $0756,472SEC↗
XLO Xilio Therapeutics, Inc. C Conversion2021-10-262021-10-28756,472— $0756,472SEC↗
XLO Xilio Therapeutics, Inc. P Buy2021-10-262021-10-28387,500$16.00 $6.20M1,143,972SEC↗
XLO Xilio Therapeutics, Inc. P Buy2021-10-262021-10-28387,500$16.00 $6.20M1,143,972SEC↗
DALS DA32 Life Science Tech Acq D To issuer deriv2021-08-052021-08-09701,250— $04,465,000SEC↗
NUVL Nuvalent, Inc. C Conversion deriv2021-08-022021-08-044,831,384— $00SEC↗
NUVL Nuvalent, Inc. C Conversion deriv2021-08-022021-08-0445,716,568— $013,011,988SEC↗
NUVL Nuvalent, Inc. C Conversion deriv2021-08-022021-08-0445,716,568— $013,011,988SEC↗
NUVL Nuvalent, Inc. C Conversion deriv2021-08-022021-08-0413,011,988— $00SEC↗
NUVL Nuvalent, Inc. C Conversion deriv2021-08-022021-08-0413,011,988— $00SEC↗
NUVL Nuvalent, Inc. C Conversion deriv2021-08-022021-08-044,831,384— $00SEC↗
NUVL Nuvalent, Inc. C Conversion deriv2021-08-022021-08-042,417,628— $02,417,628SEC↗
NUVL Nuvalent, Inc. C Conversion deriv2021-08-022021-08-042,417,628— $02,417,628SEC↗
NUVL Nuvalent, Inc. P Buy deriv2021-08-022021-08-04300,000$17.00 $5.10M2,717,628SEC↗
NUVL Nuvalent, Inc. P Buy deriv2021-08-022021-08-04300,000$17.00 $5.10M2,717,628SEC↗
NUVL Nuvalent, Inc. C Conversion2021-08-022021-08-048,494,140— $08,772,840SEC↗
NUVL Nuvalent, Inc. C Conversion2021-08-022021-08-048,494,140— $08,772,840SEC↗
NUVL Nuvalent, Inc. C Conversion2021-08-022021-08-04897,671— $09,670,511SEC↗
NUVL Nuvalent, Inc. C Conversion2021-08-022021-08-04897,671— $09,670,511SEC↗
DALS DA32 Life Science Tech Acq A Award2021-07-302021-08-03650,000$10.00 $6.50M2,250,000SEC↗
DALS DA32 Life Science Tech Acq P Buy2021-07-302021-08-031,600,000$10.00 $16.00M1,600,000SEC↗
NUVL Nuvalent, Inc. A Award deriv2021-07-282021-07-3043,000— $043,000SEC↗
NUVL Nuvalent, Inc. A Award deriv2021-07-282021-07-3043,000— $043,000SEC↗
AFIB Acutus Medical, Inc. P Buy2021-07-192021-07-21390,836$14.00 $5.47M1,974,638SEC↗
AFIB Acutus Medical, Inc. P Buy2021-07-192021-07-21680,592$14.00 $9.53M3,438,589SEC↗
MIRM Mirum Pharmaceuticals, Inc S Sale2021-07-092021-07-1399,325$15.81 $1.57M0SEC↗
MIRM Mirum Pharmaceuticals, Inc S Sale2021-07-072021-07-076,837$15.87 $108.5K99,325SEC↗
MIRM Mirum Pharmaceuticals, Inc S Sale2021-07-062021-07-0749,239$16.20 $797.7K106,162SEC↗
MIRM Mirum Pharmaceuticals, Inc S Sale2021-07-022021-07-0710,599$17.01 $180.3K155,401SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2021-06-302021-07-02228,571$8.75 $2.00M1,943,423SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2021-06-302021-07-02228,569$8.75 $2.00M1,943,406SEC↗
LRMR Larimar Therapeutics, Inc. P Buy2021-06-302021-07-02228,570$8.75 $2.00M1,943,420SEC↗
AFIB Acutus Medical, Inc. A Award deriv2021-06-172021-09-027,022— $07,022SEC↗
AFIB Acutus Medical, Inc. A Award2021-06-172021-09-021,800— $04,022SEC↗
CMAX Deerfield Healthcare Techn M Exercise deriv2021-06-082021-06-103,368,750— $00SEC↗
CMAX Deerfield Healthcare Techn M Exercise deriv2021-06-082021-06-1050,000— $00SEC↗
CMAX Deerfield Healthcare Techn J Other deriv2021-06-082021-06-10672,000— $0672,000SEC↗
CMAX Deerfield Healthcare Techn A Award deriv2021-06-082021-06-102,916,667— $02,916,667SEC↗
CMAX Deerfield Healthcare Techn A Award2021-06-082021-06-109,600,000$10.00 $96.00M12,960,000SEC↗
CMAX Deerfield Healthcare Techn A Award2021-06-082021-06-10400,000$10.00 $4.00M400,000SEC↗
CMAX Deerfield Healthcare Techn M Exercise2021-06-082021-06-103,368,750— $03,768,750SEC↗
CMAX Deerfield Healthcare Techn M Exercise2021-06-082021-06-1050,000— $050,000SEC↗
OMIC Singular Genomics Systems, C Conversion deriv2021-06-012021-06-030— $00SEC↗
OMIC Singular Genomics Systems, C Conversion deriv2021-06-012021-06-030— $00SEC↗
OMIC Singular Genomics Systems, C Conversion deriv2021-06-012021-06-036,457,723— $00SEC↗
OMIC Singular Genomics Systems, P Buy2021-06-012021-06-03450,000$22.00 $9.90M7,484,871SEC↗
OMIC Singular Genomics Systems, C Conversion2021-06-012021-06-03577,148$17.60 $10.16M577,148SEC↗
OMIC Singular Genomics Systems, C Conversion2021-06-012021-06-03577,148$17.60 $10.16M7,034,871SEC↗
OMIC Singular Genomics Systems, C Conversion2021-06-012021-06-036,457,723— $06,457,723SEC↗
OMIC Singular Genomics Systems, P Buy2021-06-012021-06-031,050,000$22.00 $23.10M1,627,148SEC↗
LRMR Larimar Therapeutics, Inc. A Award deriv2021-05-122021-05-178,300— $08,300SEC↗
HOWL Werewolf Therapeutics, Inc C Conversion deriv2021-05-042021-05-0415,195,094— $00SEC↗
HOWL Werewolf Therapeutics, Inc P Buy2021-05-042021-05-04800,000$16.00 $12.80M2,552,787SEC↗
HOWL Werewolf Therapeutics, Inc C Conversion2021-05-042021-05-041,752,787— $01,752,787SEC↗
EWTX Edgewise Therapeutics, Inc C Conversion deriv2021-03-302021-03-301,572,960— $00SEC↗
EWTX Edgewise Therapeutics, Inc C Conversion deriv2021-03-302021-03-30433,551— $00SEC↗
EWTX Edgewise Therapeutics, Inc C Conversion deriv2021-03-302021-03-301,301,626— $00SEC↗
EWTX Edgewise Therapeutics, Inc P Buy2021-03-302021-03-30625,000$16.00 $10.00M3,933,137SEC↗
EWTX Edgewise Therapeutics, Inc C Conversion2021-03-302021-03-301,301,626— $02,874,586SEC↗
EWTX Edgewise Therapeutics, Inc C Conversion2021-03-302021-03-301,572,960— $01,572,960SEC↗
EWTX Edgewise Therapeutics, Inc C Conversion2021-03-302021-03-30433,551— $03,308,137SEC↗
ONCR Oncorus, Inc. P Buy2021-02-172021-02-1832,884$19.00 $624.8K345,167SEC↗
ONCR Oncorus, Inc. P Buy2021-02-172021-02-18133,558$19.00 $2.54M1,401,905SEC↗
ONCR Oncorus, Inc. P Buy2021-02-172021-02-18133,558$19.00 $2.54M1,401,905SEC↗
TERN Terns Pharmaceuticals, Inc C Conversion deriv2021-02-092021-02-091,717,033— $00SEC↗
TERN Terns Pharmaceuticals, Inc P Buy2021-02-092021-02-09665,000$17.00 $11.30M2,382,033SEC↗
TERN Terns Pharmaceuticals, Inc C Conversion2021-02-092021-02-091,717,033— $01,717,033SEC↗
LUMO LUMOS PHARMA, INC. S Sale2021-01-082021-01-081,000$24.11 $24.1K890,080SEC↗
LUMO LUMOS PHARMA, INC. S Sale2021-01-082021-01-08101,600$22.24 $2.26M784,568SEC↗
LUMO LUMOS PHARMA, INC. S Sale2021-01-082021-01-083,912$23.57 $92.2K886,168SEC↗
LUMO LUMOS PHARMA, INC. S Sale2021-01-072021-01-084,378$25.05 $109.7K891,080SEC↗
LUMO LUMOS PHARMA, INC. S Sale2021-01-072021-01-0811,794$24.35 $287.2K895,458SEC↗
LUMO LUMOS PHARMA, INC. S Sale2021-01-062021-01-08931$22.64 $21.1K907,252SEC↗
LUMO LUMOS PHARMA, INC. S Sale2021-01-062021-01-0828,108$22.47 $631.6K908,183SEC↗
ONCR Oncorus, Inc. C Conversion deriv2020-10-062020-10-082,449,761— $00SEC↗
ONCR Oncorus, Inc. C Conversion deriv2020-10-062020-10-087,499,999— $00SEC↗
ONCR Oncorus, Inc. C Conversion deriv2020-10-062020-10-087,499,999— $00SEC↗
ONCR Oncorus, Inc. C Conversion deriv2020-10-062020-10-082,449,761— $00SEC↗
ONCR Oncorus, Inc. C Conversion deriv2020-10-062020-10-082,449,761— $00SEC↗
ONCR Oncorus, Inc. C Conversion2020-10-062020-10-08202,670— $0823,150SEC↗
ONCR Oncorus, Inc. P Buy2020-10-062020-10-08445,194$15.00 $6.68M1,268,344SEC↗
ONCR Oncorus, Inc. P Buy2020-10-062020-10-08445,194$15.00 $6.68M1,268,344SEC↗
ONCR Oncorus, Inc. C Conversion2020-10-062020-10-08202,670— $0202,670SEC↗
ONCR Oncorus, Inc. P Buy2020-10-062020-10-08109,612$15.00 $1.64M312,282SEC↗
ONCR Oncorus, Inc. C Conversion2020-10-062020-10-08202,670— $0823,150SEC↗
ONCR Oncorus, Inc. C Conversion2020-10-062020-10-08620,480— $0620,480SEC↗
ONCR Oncorus, Inc. C Conversion2020-10-062020-10-08620,480— $0620,480SEC↗
LRMR Larimar Therapeutics, Inc. A Award deriv2020-09-292020-10-0116,600— $016,600SEC↗
GRAY GRAYBUG VISION, INC. C Conversion deriv2020-09-292020-10-012,624,901— $00SEC↗
GRAY GRAYBUG VISION, INC. C Conversion deriv2020-09-292020-10-012,624,901— $00SEC↗
GRAY GRAYBUG VISION, INC. C Conversion deriv2020-09-292020-10-0112,809,912— $00SEC↗
GRAY GRAYBUG VISION, INC. C Conversion deriv2020-09-292020-10-0112,809,910— $00SEC↗
GRAY GRAYBUG VISION, INC. C Conversion deriv2020-09-292020-10-012,624,901— $00SEC↗
GRAY GRAYBUG VISION, INC. C Conversion2020-09-292020-10-01291,467— $0291,467SEC↗
GRAY GRAYBUG VISION, INC. C Conversion2020-09-292020-10-01291,467— $01,713,873SEC↗
GRAY GRAYBUG VISION, INC. P Buy2020-09-292020-10-011,562,500$16.00 $25.00M1,853,967SEC↗
GRAY GRAYBUG VISION, INC. C Conversion2020-09-292020-10-011,422,406— $01,422,406SEC↗
GRAY GRAYBUG VISION, INC. C Conversion2020-09-292020-10-011,422,406— $01,422,406SEC↗
GRAY GRAYBUG VISION, INC. C Conversion2020-09-292020-10-01291,467— $01,713,873SEC↗
AFIB Acutus Medical, Inc. C Conversion deriv2020-08-102020-08-12449,992— $00SEC↗
AFIB Acutus Medical, Inc. C Conversion deriv2020-08-102020-08-121,002,464— $00SEC↗
AFIB Acutus Medical, Inc. C Conversion deriv2020-08-102020-08-12189,366— $00SEC↗
AFIB Acutus Medical, Inc. C Conversion deriv2020-08-102020-08-121,199,980— $00SEC↗
AFIB Acutus Medical, Inc. C Conversion2020-08-102020-08-121,199,980— $01,199,980SEC↗
AFIB Acutus Medical, Inc. P Buy2020-08-102020-08-12944,444$18.00 $17.00M1,583,802SEC↗
AFIB Acutus Medical, Inc. C Conversion2020-08-102020-08-121,002,464— $02,202,444SEC↗